2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College …

SM Al-Khatib, WG Stevenson, MJ Ackerman… - Journal of the American …, 2018 - jacc.org
The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart …

WK Shen, RS Sheldon, DG Benditt, MI Cohen… - Journal of the American …, 2017 - jacc.org
The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

JCS/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias

K Ono, Y Iwasaki, M Akao, T Ikeda, K Ishii… - Circulation …, 2022 - jstage.jst.go.jp
The Japanese Circulation Society (JCS) published the “Guidelines for Pharmacological
Treatment of Arrhythmia” in 2004, and a revised edition was published in 2009. 1 Both …

Calcium signaling and cardiac arrhythmias

AP Landstrom, D Dobrev, XHT Wehrens - Circulation research, 2017 - Am Heart Assoc
There has been a significant progress in our understanding of the molecular mechanisms by
which calcium (Ca2+) ions mediate various types of cardiac arrhythmias. A growing list of …

[HTML][HTML] HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes

SG Priori, AA Wilde, M Horie, Y Cho, ER Behr… - Journal of …, 2014 - Elsevier
This international consensus statement is the collaborative effort of three medical societies
representing electrophysiology in North America, Europe and Asian-Pacific area: the Heart …

Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes

SG Priori, AA Wilde, M Horie, Y Cho, ER Behr… - Europace, 2013 - academic.oup.com
HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients
with inherited primary arrhythmia syndromes | EP Europace | Oxford Academic Skip to Main …

EHRA/HRS/APHRS expert consensus on ventricular arrhythmias

CT Pedersen, GN Kay, J Kalman, M Borggrefe… - Europace, 2014 - academic.oup.com
This international consensus statement of the European Heart Rhythm Association (EHRA),
Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society is intended to provide …

Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia

M Hayashi, I Denjoy, F Extramiana, A Maltret… - Circulation, 2009 - Am Heart Assoc
Background—The pathophysiological background of catecholaminergic polymorphic
ventricular tachycardia is well understood, but the clinical features of this stress-induced …

Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia

MJ Wleklinski, PJ Kannankeril… - The Journal of …, 2020 - Wiley Online Library
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a stress‐induced cardiac
channelopathy that has a high mortality in untreated patients. Our understanding has grown …

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia

C van der Werf, PJ Kannankeril, F Sacher… - Journal of the American …, 2011 - jacc.org
Objectives: This study evaluated the efficacy and safety of flecainide in addition to
conventional drug therapy in patients with catecholaminergic polymorphic ventricular …